About Remus Pharmaceuticals
The shares listed at ₹1,711.25, a 39.24% move from the issue price. Remus Pharmaceuticals is a SME IPO with an issue size of ₹47.69 crore, proposed for listing on NSE SME. The offer opens on 17th May 2023 and closes on 19th May 2023. The issue structure includes a fresh issue of ₹45.29 crore. The current listing schedule points to 29th May 2023.
Company Contact
Address—
Phone—
Websitehttps://www.ipomatrix.com/